Skip to content

Comparative clinical evaluation of trikatu churna and kalbhojanam in sthoulya.

Comparative clinical evaluation of trikatu churna and kalbhojanam in sthoulya.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/047896
Enrollment
96
Registered
2022-12-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E663- Overweight Health Condition 2: E663- Overweight

Interventions

None listed

Sponsors

Priyanka Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient willing to sign the consent form.2.The patients between the age group of 18 to 50 years of either sex presenting with clinical features of Sthaulya (obesity).4. Patients having BMI more than or equal to 25Kg/m2.

Exclusion criteria

Exclusion criteria: 1. Age below 18 and above 50 years. 2. Patients with complicated and chronic disorder like nephroticsyndrome, hypothyroidism, jaundice, hepatitis, chronic infections andother serious diseases. 3. Patients having Obesity due to secondary causes such as druginduced or hormonal imbalance like contraceptive pills. 4. Pregnant women and lactating mother. 5. Patients suffering from Diabetes mellitus . 6. Systemic illness like Tuberculosis, Carcinoma and Endocrinedisorders like Cushing syndrome, Hypothyroidism. 7. Patient having the past history of M.I. & Unstable Angina. 8. Patient having Clinical Features of CCF. 9. Patient having the major renal or liver disorder.

Design outcomes

Primary

MeasureTime frame
1. Change in body weight. 2. Changes in BMI. 3. Changes in anthropometric parameters. 4. Changes in skin folds thickness. 5. Changes in lipid profile Timepoint: All measure in Time Frame: 30th day, 60th day, 90th day, 120th day.

Secondary

MeasureTime frame
1. Reduction in risk of type 2 diabetes mellitus Will be assessed by fasting blood sugar level and Indian Diabetes Risk Score. 2. Reduction in risk of Coronaryarterydiseasewill be assessed by FRAMINGHMS 10 years cardiac risk score).Timepoint: Time Framefor both: 30th day, 90th days and 120thth day

Countries

India

Contacts

Public ContactAvadhesh Kumar

Gurukul campus,UAU,Haridwar

dr.avadheshmishra@gmail.com8630287151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026